In NOD mice, CXCL13 blockade disrupted B-cell organization in islet ELSs, however, neither the proportion of B-cell within the islets, nor the T1DM disease progression were affected (172). The gene discussed is CXCL13; the disease is type 1 diabetes mellitus.